2018
DOI: 10.1016/j.toxrep.2018.11.002
|View full text |Cite
|
Sign up to set email alerts
|

The clinical toxicology of caffeine: A review and case study

Abstract: Caffeine is a widely recognized psychostimulant compound with a long history of consumption by humans. While it has received a significant amount of attention there is still much to be learned with respect to its toxicology in humans, especially in cases of overdose. A review of the history of consumption and the clinical toxicology of caffeine including clinical features, pharmacokinetics, toxicokinetics, a thorough examination of mechanism of action and management/treatment strategies are undertaken. While h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
138
0
34

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 183 publications
(186 citation statements)
references
References 182 publications
1
138
0
34
Order By: Relevance
“…The pharmacology of caffeine and related methylxanthines is complex, as they modulate a variety of biological targets. Nevertheless, clinical and experimental investigations of caffeine pharmacology provide biological plausibility to some of these effects, as outlined in a recent comprehensive review [37]. At physiologically relevant concentrations, the predominant pharmacological effect is as a purinoceptor antagonist.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The pharmacology of caffeine and related methylxanthines is complex, as they modulate a variety of biological targets. Nevertheless, clinical and experimental investigations of caffeine pharmacology provide biological plausibility to some of these effects, as outlined in a recent comprehensive review [37]. At physiologically relevant concentrations, the predominant pharmacological effect is as a purinoceptor antagonist.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, positive allosteric modulators of A1A have been proposed as a therapeutic strategy for anxiety [38]. Based upon laboratory observations, it is often claimed that caffeine is a phosphodiesterase inhibitor, however, this action is unlikely to occur, at any but the very highest concentrations in vivo, and the relevance to anxiety is unclear [37].…”
Section: Discussionmentioning
confidence: 99%
“…It is noteworthy that histamine and caffeine might cause certain health pathologies in high concentrations, e.g., human pregnancy complications [100], urticaria [101], and cardiovascular diseases [102] respectively. Thus, the right doses need to be applied.…”
Section: Does Caffeine Augment Histamine-mediated Lipolysis In Adiposmentioning
confidence: 99%
“…Adults over the age of 25 years have an estimated consumption of approximately 2.4 mg/kg/day. In the literature, the average daily consumption of caffeine varied depending on the survey, year conducted, and the sources considered [28]. However, it has most recently (i.e., 2011 -2012) been reported as 142 mg per day for adults and children in the US, a decrease from previous years (e.g., the average consumption of 175 mg/day in 1999 -2000), which is largely attributed to a reduction in soda consumption.…”
Section: Discussionmentioning
confidence: 99%
“…However, it has most recently (i.e., 2011 -2012) been reported as 142 mg per day for adults and children in the US, a decrease from previous years (e.g., the average consumption of 175 mg/day in 1999 -2000), which is largely attributed to a reduction in soda consumption. Caffeine is known to have generally dosedependent effects with positive or desirable effects at lower doses (i.e., ≤ 400 mg) and undesirable effects generally above this level of intake [28].…”
Section: Discussionmentioning
confidence: 99%